Physician profile
Stephen Refsland
NPI 1922329572
$5,179.63
in general payments reported to CMS, 2019-2025
12 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $115 · 2021: $154 · 2022: $1,356 · 2023: $294 · 2024: $2,509 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,725 · Travel and Lodging: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.58 |
| Travel and Lodging | $1,321.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $1,800.53 | 2022-2024 | |
| Sonex Health, INC. | $1,788.04 | 2024-2025 | Sx-One Microknife |
| Electronic Waveform Lab, INC. | $547.94 | 2019-2024 | |
| Smith+Nephew, INC. | $481.04 | 2019-2023 | Evos |
| Depuy Synthes Sales INC. | $186.55 | 2019-2025 | Quickanchor Ethibond, Truespan Orthocord, Dynatape |
| Exsomed Corporation | $95.31 | 2019 | |
| Anika Therapeutics, INC. | $92.65 | 2021-2022 | |
| Arthrex, INC. | $86.85 | 2020-2024 | |
| Vertex Pharmaceuticals Incorporated | $33.79 | 2024 | |
| Acumed LLC | $27.68 | 2021 | |
| Zimmer Biomet Holdings, INC. | $25.00 | 2024 | Tapestry |
| Baxter Healthcare | $14.25 | 2025 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Refsland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.